abstract |
The present invention relates to the use of potent potassium channel blockers or combinations thereof in the treatment of glaucoma and other conditions that lead to increased intraocular pressure in the patient's eye. The invention also relates to the use of such compounds for conferring neuroprotective effects on mammalian species, in particular the human eye. |